Dear All

The time to start the eradication project of hepatitis C is now

We ask from all physicians from the world especially from Middle East region to join us for therapy more cases with HCV infection in their countries

  I would like to share with you some information about viral hepatitis in the region. Viral hepatitis B and C are important public health hazards in our region and many of our peoples are infected with these infections. HBV and HCV are the main cause of chronic liver diseases such liver cirrhosis and hepatocellular carcinoma and we loss many of them every year. Both infections are preventable and for HBV, we have power and effective vaccine and for HCV, we have good strategies for prevention in the communities. Dialogue between Scientists in different countries is an interactive communications network and an educational forum contributing, through global dialogue, towards the solutions of current issues directly affecting the identity, self-determination and presence of Indigenous Peoples in the modern world. I would like to share with others our experiences in this issue

We have good achievements in control and treatment of HCV and HBV infections in Iran. The drugs are variables in Iran with low prizes and high efficacy. Sofosbovir, ledipasvir and daclatasvir with very low prizes are available. It is possible to send your patients to equipped centers in Iran for getting the drugs

It is the time to cover more patients in your practice for getting the new drugs. Today should act, tomorrow is late

DSC06082

However, I would like to introduce you MELD Center (www.meldcenter.com) and for Global scientists (www.hepcomm.com ) for more detail.  It is my pleasure to share my experience with you.

Kind Regards,

Seyed Moayed Alavian, MD.

Professor in Medicine, Hepatologist

Director of Middle East Liver Disease Center

Editor-in-chief of Hepatitis Monthly

E mail: alavian@thc.ir , editor@hepatmon.com

Iran-Tehran clinic: www.meldcenter.com

Iran-Kish Island : http://www.kishhospitalfz.com/home/fa/

Tel: +98 21 88945186-7

Fax: +98 21 88945188